Merck KGaA Opens New Testing Facility at German HQ

08:48 AM EDT, 07/16/2026 (MT Newswires) -- Merck KGaA (MRK.F) said Thursday it opened a new BioReliance testing facility at its headquarters in Darmstadt, Germany, amid growing demand for biologics and novel therapies. The 25 million-euro, 2,000-square-meter facility expands the German science and technology company's network for testing commercial drug substances and drug product releases in Europe.